Cargando…
MiR-181b sensitizes glioma cells to teniposide by targeting MDM2
BACKGROUND: Although the incidence of glioma is relatively low, it is the most malignant tumor of the central nervous system. The prognosis of high-grade glioma patient is very poor due to the difficulties in complete resection and resistance to radio-/chemotherapy. Therefore, it is worth investigat...
Autores principales: | Sun, Yan-chang, Wang, Jing, Guo, Cheng-cheng, Sai, Ke, Wang, Jian, Chen, Fu-rong, Yang, Qun-ying, Chen, Yin-sheng, Wang, Jie, To, Tony Shing-shun, Zhang, Zong-ping, Mu, Yong-gao, Chen, Zhong-ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155117/ https://www.ncbi.nlm.nih.gov/pubmed/25151861 http://dx.doi.org/10.1186/1471-2407-14-611 |
Ejemplares similares
-
Curative effect of methotrexate combined with teniposide in the treatment of primary central nervous system lymphoma
por: Wang, Yi-Xia, et al.
Publicado: (2020) -
miR-29a sensitizes the response of glioma cells to temozolomide by modulating the P53/MDM2 feedback loop
por: Chen, Qiudan, et al.
Publicado: (2021) -
MiR-181b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cells()
por: Li, Ping, et al.
Publicado: (2010) -
Topoisomerase II trapping agent teniposide induces apoptosis and G2/M or S phase arrest of oral squamous cell carcinoma
por: Li, Jinzhong, et al.
Publicado: (2006) -
RPN2 is targeted by miR-181c and mediates glioma progression and temozolomide sensitivity via the wnt/β-catenin signaling pathway
por: Sun, Jikui, et al.
Publicado: (2020)